| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 762148 | N-(4-{2-[(1R,6R,11aS,13S,14aR)-1,13-dihydroxy-4-oxo-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-6-yl]ethyl}phenyl)-N'-(3',6'-dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9'-xanth | 0.04831289866584 | -0.12994669 |
| NSC 84092 | Null | 0.04831289866584 | 0.16062277 |
| NSC 87197 | Null | 0.04831289866584 | 0.20738226 |
| NSC 113497 | 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) | 0.0490935610249067 | 0.21553903 |
| NSC 114346 | Null | 0.0490935610249067 | 0.2747405 |
| NSC 129794 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.0490935610249067 | 0.099534526 |
| NSC 132313 | Dianhydrogalactitol | 0.0490935610249067 | 0.30437518 |
| NSC 163424 | 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- | 0.0490935610249067 | 0.24665233 |
| NSC 166382 | Null | 0.0490935610249067 | 0.086325898 |
| NSC 18805 | .gamma.-Thujaplicine | 0.0490935610249067 | 0.32119414 |